New study shows RNA polymerase I halts at abasic DNA damage, helping prevent faulty rRNA production and exposing lesions for ...

A promising new treatment to combat "undruggable" cancers has been green-lit for a human trial in 2025. It's hoped the novel ...

Despite a 32.76% drop in the past 30 days, analysts foresee a potential 0.47% price increase for POL in March. Expected trading prices range between $0.192 and $0.225, with an average of $0.206.